ACC: Antithrombotic Benefit Found Lacking in Low-Risk A-Fib
Researchers found low-risk patients fared better without any antithrombotic therapy
ACC: Meds Targeting PCSK9 Show Benefit for High-Risk Patients
Evolocumab and inclisiran inhibit proprotein convertase subtilisin-kexin type 9
Thiamine May Reduce Progression to Renal Replacement Therapy
Findings for patients in septic shock
Supervised Self-Injection Ups Teens’ Comfort With Approach
Findings show improved comfort with self-injection, reduced anxiety for food-allergic adolescents
Clinical Decision Support System Use Tied to Fewer VTE Events
Increase in rate of appropriate ordering for VTE prophylaxis; reduction in risk of VTE events
Short Course of Intensive Lifestyle, Drug Tx Helpful in T2DM
More participants achieve normoglycemia on therapy versus standard diabetes care
Concurrent Benzodiazepine, Opioid Use Up Significantly
Providers urged to exercise caution in prescribing opioids for patients already using benzodiazepines
Economic Benefit for Lifestyle Modification in Prediabetes
Three-year return on investment for prevention program estimated to be as high as 42 percent
Immune Responses to Ebola Vaccines Persist at One Year
All active vaccine recipients maintained Ebola virus-specific immunoglobulin responses at day 360
AAOS: Few Hip Fracture Patients Take Vitamin D Consistently
Correlation for consistent supplementation with increase in physical component of the SF-12 score
